neuroinflammation, 14 toxic blood degradation products, 5,15 and endocrine abnormalities. 16 Still, it is not fully elucidated why GCE resolves rapidly in some SAH patients whereas other suffer from prolonged brain edema. Moreover, it is not known whether resolution of brain edema may serve as a potential treatment target and whether the time to resolution should be used in a multimodal approach to predict outcome.
G lobal cerebral edema (GCE) is commonly observed after subarachnoid hemorrhage (SAH) and was identified as prognostic factor for poor functional outcome. [1] [2] [3] [4] [5] In a substantial proportion of patients, GCE is detected on admission computed tomography (CT) scan (6%-57%) 1, 3, 6, 7 and develops in up to 12% in the delayed phase after SAH. 1 Underlying pathophysiologic mechanisms are complex and insufficiently studied in humans. Raised intracranial pressure followed by brain circulatory arrest may trigger early GCE through cytotoxic edema. 8, 9 This hypothesis is supported by the associated loss of consciousness in patients with early GCE. 1, 10 Progressive ischemia initiates an apoptotic cascade leading to blood-brain barrier breakdown and vasogenic edema. 11, 12 Other risk factors for blood-brain barrier dysfunction and hence prolonged edema include autoregulatory failure, Identification and quantification of GCE on CT scans are difficult and dichotomization lacks sensitivity. More recently, a CT-based semiquantitative measuring method (subarachnoid hemorrhage early brain edema score [SEBES] ) was introduced as radiographic surrogate marker of early brain injury. The SEBES grade is quantified by the absence of visible sulci at 2 predefined brain tissue levels in each hemisphere, ranging from 0 (no edema) to 4 (GCE). It is a neuroradiologic score which can be easily assessed in a timely fashion. 17 The concept of early brain injury gains increasing attention in research because understanding the underlying pathophysiology may enable us to apply specific treatment to these patients to improve the clinical course and outcome. Recent data suggest that blood-brain barrier breakdown, metabolic derangement, excitotoxicity, and neuroinflammation occur within 72 hours after SAH 11, 18 and may even be aggravated in patients with GCE. 19 More and more data indicate that early brain injury is associated with secondary complications such as delayed cerebral ischemia as well as poor functional outcome. 11, 18 In line with these findings, the SEBES grade was associated with delayed cerebral ischemia and poor functional outcome. 17 In this study, we aimed to quantify brain edema longitudinally and to describe its resolution based on the SEBES score. Furthermore, we intended to find associated factors with prolonged brain edema and study its impact on functional outcome. We hypothesized that delayed edema resolution is associated with worse outcome.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Study Design, Setting, and Patient Selection
The study design was guided by the STROBE statement on observational cohort studies. This is a retrospective analysis of prospectively collected observational data of 324 consecutive patients with nontraumatic SAH admitted between 2010 and 2017 to the neurological intensive care unit of a tertiary hospital (Medical University of Innsbruck). Inclusion criteria encompassed (1) nontraumatic SAH, (2) age ≥18 years, and (3) intensive care unit stay for at least 24 hours. Patients with (1) arteriovenous malformations, (2) refusal of consent, (3) late admission (>7 days of onset; together N=28), or (4) osteoplastic craniectomy (N=13) were excluded leaving 283 patients eligible for final analysis. The conduct of the study was approved by the local ethics committee (Medical University of Innsbruck, AM4091-292/4.6). Written informed consent was obtained according to Austrian law and in accordance with the Declaration of Helsinki.
Patient Management and Grading
Management of patients after SAH conformed to international guidelines. 20, 21 Ruptured aneurysms were secured by clipping or coiling. As a modification to current guidelines, prophylactic nimodipine was applied intravenously in poor-grade SAH patients, otherwise nimodipine was administered orally. Patients' baseline characteristics, hospital complications, and outcomes were prospectively collected by weekly meetings of the study team and treating neurointensivists. All patients were followed for vasospasm with repetitive transcranial color-coded duplex sonography (LOGIQ S8, GE Healthcare, Chicago, IL). Vasospasm was defined as an elevation of mean velocities >120 cm/s in the middle or anterior cerebral artery or daily change in mean transcranial color-coded duplex velocities >50 cm/s. Severe vasospasm (>200 cm/s) was further confirmed by catheter cerebral angiogram and treated with intraarterial nimodipine.
Delayed cerebral ischemia was defined as clinical deterioration (decrease of ≥2 points on the Glasgow Coma Scale), the occurrence of a new focal neurological deficit or a new infarction on CT or magnetic resonance imaging scan not attributable to other causes. 22 The treatment of intracranial hypertension included osmotherapy with mannitol (15%) or hypertonic saline (10%) infusions.
Functional outcome was assessed at 3 months postbleeding by a study nurse blinded to the clinical course of the patient using the modified Rankin Scale score.
Data Collection and Edema Quantification
Continuous variables were recorded in a patient data management system (CentricityTM Critical Care 8.1 SP7; GE Healthcare Information Technology, Dornstadt Germany). All cerebral CT scans over the first 15 days were quantified by an independent rater blinded to clinical data using the SEBES grade (range 0-4). The SEBES was assessed by assigning one point for the absence of visible sulci either because of effacement of sulci or loss of gray-white differentiation at 2 predetermined levels in each hemisphere: (1) at the level of the insular cortex where the thalamus and basal ganglion are visible, above the basal cistern and (2) at the level of the centrum semiovale above the level of the lateral ventricle. In patients where high-grade SEBES (3 or 4 points) was detected, the SEBES grade was determined on all subsequent CT scans of the brain until resolution of cerebral edema (≤2 points) was documented. All available head CT scans performed according to clinical necessity were examined.
Statistical Methods
Continuous variables were assessed for normality and reported as mean±SEM or median and interquartile range (IQR). The SEBES grade was treated as an ordinal variable or divided in 3 categories (high-grade, low-grade (1-2) SEBES, and no edema) and indicated accordingly. Time to resolution of high-grade SEBES in all patients was at median 8 days after SAH. Patients were, therefore, dichotomized as early (<8 days) and delayed (≥8 days) edema resolution. In 7 young patients, in whom high-grade SEBES was detected, no follow-up CT scan was pursued because of significant clinical improvement. These patients were considered to have early edema resolution. Discharge modified Rankin Scale was carried forward for patients (N=3/80) who were lost to 3-month follow-up and used as an ordinal dependent variable. Minimum and maximum serum electrolytes and WBC count over the first 72 hours, daily amounts of fluids given, fluid balance and urine output (in L) were investigated and used as independent variables. Optimal cutoff points for sodium, chloride, and leukocytes were evaluated by the Youden index to find the maximal sum of sensitivity and specificity. The day of admission was denoted as day 0 (first 24 hours). Univariate associations between clinically meaningful variables and delayed edema resolution as well as worse functional outcome in patients surviving at least 15 days were tested using the t test, MannWhitney U test, Fishers exact-test, or generalized linear models, as appropriate. Generalized estimating equations with the correlation matrix best fitting the data were used to account for repeated measurements. Multivariable analysis was done with use of generalized linear models. Both, clinically important variables and variables with a P<0.1 in univariate analysis were included stepwise in the logistic regression models and retained if significant (P<0.05) except for Hunt and Hess (H&H) grade and age, which were kept in all models. Cases with missing values were included. All analyses and graphical representations were performed with IBM-SPSS V24.0 (SPSS Inc, Armonk, NY), MedCalc V18.9.1 (MedCalc Software bvba, Ostend, Belgium), and Prism 5 for Windows V5.01 (GraphPad Software, Inc, LA Jolla, CA).
Results

Study Population
Of 324 screened patients, 283 met inclusion criteria. Detailed information on baseline characteristics, hospital complications, and outcome is provided in Table 1 . In total 936 CT
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April 2019 (28) 45 (43) 29 (27) 6 (8) 2 56 (29) 27 (26) 22 (21) 7 (10) 3 45 (16) 14 (14) 17 (16) 14 (19) 4 16 (6) 3 (3) 10 (9) 3 (4) 5 86 (30) 15 (14) 28 (26) 43 (59) Preexisting hypertension 113 (40) 47 (45) 43 (41) 23 (32) Diabetes mellitus 17 (6) 6 (6) 7 (7) 4 (6) LOC at ictus 107 (38) 23 (22) 42 (40) 42 (58) Admission radiological characteristics
Modified Fisher Scale 1 39 (14) 22 (21) 14 (13) 3 (4) 2 40 (14) 16 (15) 19 (18) 5 (7) 3 65 (23) 29 (28) 22 (21) 14 (19) 4 139 (49) 37 (36) 51 (48) 51 (70) ICH present on admission CT scan 51 (18) 9 (9) 22 (21) 20 (28) Hydrocephalus requiring EVD placement 130 (46) 35 (34) 47 (44) 48 (66) Aneurysm size, mm 6 (4-8) (12) 14 (14) 13 (12) 8 (11) 6 52 (18) 12 (12) 19 (18) 21 (29) Data are given in median (IQR) and counts (%). CT indicates computed tomography; EVD, external ventricular drain; H&H, Hunt and Hess; ICH, intracerebral hemorrhage; ICU, intensive care unit; LOC, loss of consciousness; mRS, modified Rankin Scale; SAH, subarachnoid hemorrhage; and SEBES, subarachnoid hemorrhage early brain edema score.
*Patients were aneurysm negative in repeated cerebral angiogram 2-3 wk apart.
scans of the head were assessed for the SEBES grade. The first CT scan was obtained within 2 (IQR=1-7) hours after the bleeding onset. Apart from the admission cerebral CT scan, a median of additionally 2 (IQR=1-4) CT scans were obtained per patient. In the subgroup of surviving patients with initial high-grade SEBES a median of 4 (IQR=3-6) CT scans were performed during the study time. In these patients, 2 (IQR=2-3) CT scans were performed within the first 72 hours, 1 (IQR=1-2) between days 3-7 and 1 (IQR=1-2) thereafter. One hundred and four patients (37%) had a SEBES grade of 0, 47 of 1 (17%), 59 of 2 (21%), 30 of 3 (11%), and 43 of 4 (15%) detected on admission CT scan.
Dynamic Changes of SEBES Grades Over 15 Days After SAH
The SEBES grade was highest on day 1 postbleeding with median 2 points (IQR=1-4) and significantly decreased over the study period (P<0.001; Figure 1A ) in all patients. A significant decrease was also observed in the subgroups with lowgrade (N=108/283, 38%) and high-grade SEBES (N=106/283, 37%), (P<0.001; Figure 1B ). The remaining 69 patients did not develop any signs of brain edema during the study period. Figure 2A) , leukocytosis (>15 G/L; adjOR, 3.14; 95% CI, 1.24-8.77; Figure 2B ) and female sex (adjOR, 3.71; 95% CI, 1.01-13.64), even after adjusting for H&H grade and age. A second model including serum chloride levels was performed to avoid assumed collinearity between sodium and chloride and revealed hyperchloremia (>121 mmol/L; adjOR, 5.24; 95% CI, 1.64-16.76; Figure 2C ) being independently associated with delayed edema resolution besides leukocytosis (>15 G/L; adjOR, 2.97; 95% CI, 1.09-8.10). The model was adjusted for H&H grade and age.
Factors Associated With High-Grade SEBES
Fluid and Electrolyte Management in High-Grade SEBES Patients
In surviving patients with high-grade SEBES, hypernatremia (>150 mmol/L) was significantly associated with higher daily urine output (OR, 1.53; 95% CI, 1. Figure 1 . Shows the subarachnoid hemorrhage early brain edema score (SEBES) grade over the first 15 days after subarachnoid hemorrhage (SAH). Mean (±SEM) SEBES significantly decreased over the study period in the (A) whole study population as well as in separate analysis of (B) high-grade (3-4 points) and low-grade (1-2 points) SEBES patients.
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SEBES Resolution and 3-Month Functional Outcome
Delayed cerebral edema resolution was associated with worse functional outcome at 3 months (Figure 3; 
Discussion
The main finding of this study is that SAH patients with delayed brain edema resolution can be identified using a simple and rapid evaluation of repeated brain CT-scans. Moreover, patients with delayed edema resolution have a significantly higher risk of worse functional outcome. To the best of our knowledge, this is the first report of a systematic approach to quantify time to resolution of brain edema following SAH. The majority of patients with high-grade SEBES were identified on admission CT scan with an incidence of 26% similar to that reported by Ahn et al. 17 For comparison, reports focusing on GCE found GCE on admission CT scans in 6% to 57% 1,3,6,7 of patients after SAH. In the current study, we also assessed the SEBES grade on all subsequent CT scans based on the assumption that the score might be suitable for quantification of edema resolution. Brain edema incidence increased to 37% within the first 72 hours, confirming previous data.
1 Reevaluation of SEBES is important since admission CT scans may not be sensitive enough to detect brain edema if performed too early. The median time from SAH onset to admission CT scan was short and lasted only 2 hours in our patients.
Concordant with previous findings, we identified admission clinical and radiographic severity markers as being independently associated with high-grade SEBES. 17 These factors simply reflect aggravated brain injury most likely related to the severity of the initial bleed. Interestingly, external ventricular drain placement did not result in acute improvement of the SEBES grade (data not shown) in our patients. In addition, younger age was independently associated with high-grade SEBES. Because of brain atrophy in elderly patients, larger sulcal volumes are observed in these patients which may decrease the susceptibility for global edema formation. 5, 23 Still, younger age was not consistently found to be associated with brain edema after SAH in previous studies. 1, 17 Little is known about the natural time course and the time to resolution of cerebral edema in SAH patients. The median time to resolution in our cohort was 8 days. When analyzing early predictors of delayed edema resolution, we identified hypernatremia and higher chloride levels. Electrolyte derangements commonly occur in the acute phase after SAH. 24 Hypernatremia has previously been shown to be associated with higher mortality and poor functional outcome following SAH. 3, 25 The cause of hypernatremia after SAH can be manifold. First, hypernatremia may reflect the severity of initial injury by compromised perfusion of the anterior hypothalamus resulting in diabetes insipidus. 26 This hypothesis is supported by the increased urinary output during hypernatremic days in our patients. Second, radiographic evidence of diffuse brain swelling may prompt clinicians to intracranial pressure monitoring and appropriate treatment including osmotherapy. Hypernatremia may, therefore, simply reflect the treatment intensity level in SAH patients. Accordingly, we found that daily osmotherapy and sodium intake were higher in patients with delayed edema resolution. Third, hypernatremia may initially result in a reduction of brain water which is compensated by accumulation of cerebral intracellular inorganic ions and organic osmolytes to adjust to hyperosmolar states. This phenomenon leads to cellular swelling during correction with isotonic fluids 27 and may be another potential explanation for sustained brain edema and delayed resolution in these patients. It is important to mention that fluid management (fluid intake, balance, and urinary output) was similar across patients with early and delayed edema resolution in our cohort. Therefore, we believe that hypernatremia primarily resulted in our patients.
In line with hypernatremia, we found an independent association between hyperchloremia and delayed brain edema resolution. In critically ill stroke patients, hyperchloremia was associated with worse functional outcome. 28 In patients with SAH, hyperchloremia was only found to be associated with acute kidney injury. 29 Similar to mechanisms leading to hypernatremia, hyperchloremia may simply be caused by diabetes insipidus or as a result of therapeutic interventions. 30 Therefore, the administration of large volumes of sodiumchloride rich fluids may be a potential modifiable factor. There is an ongoing debate on which fluids should be used for fluid resuscitation after SAH. Currently, isotonic crystalloids are recommended for fluid maintenance without preference to a specific crystalloid solution. 31 Only a small single-center randomized controlled study found an increased rate of hyperchloremia, hypernatremia, hyperosmolality, and metabolic acidosis in patients treated with saline-based fluids as compared to those treated with balanced crystalloid solutions after SAH. 32 In addition, we identified higher white blood cell counts within 72 hours as early associated factor with delayed brain edema resolution. This is of interest and connects early systemic inflammatory response with cerebral edema. 33 There is mounting evidence that neuro-hemo-inflammation is associated with disease severity and contributes to secondary brain injury after SAH. 11, 12, 34 To date it is not clear to what extent systemic inflammatory mediators may exacerbate a proinflammatory cascade in the brain tissue.
Our results indicate that there is only a small space for treatment options to influence brain edema resolution and that factors associated with delayed resolution mainly depend on the severity of the initial brain injury. Still, our data suggest that electrolyte disturbances and inflammatory markers in the early phase after SAH may help to better identify individual patients at highest risk for delayed brain edema resolution. In the contrary, our data also suggest that patients with normonatremia and normal chloride levels in the early phase after SAH may have a more rapid resolution of brain edema.
We could show that delayed brain edema resolution is an important predictor of poor functional outcome even after adjusting for well-established prognostic values such as age, clinical admission grade, and infectious complications. 24 Brain edema was previously associated with poor functional and worse cognitive outcome. 1, 17 This emphasizes the need for early effective treatment strategies for patients with cerebral edema. Unlike the primary injury, adequate patient management may attenuate progressive secondary brain injury. Initial cytotoxic edema reflecting the extent of primary injury is pursued by vasogenic edema, which may develop at the time when irreversible neuronal loss occurs. The time span for this irreversible neuronal loss encompasses the third and seventh day after bleeding, 9,35 keeping a potential therapeutic window. However, established therapeutic interventions to modulate the development of cerebral edema in SAH patients are limited. There are some data investigating the brain metabolism after SAH that found an association between brain metabolic distress and GCE. Potential mechanisms to optimize brain metabolic distress focus on increasing energy delivery and ameliorating the metabolic demand. In this line, higher cerebral perfusion pressure levels were associated with an improved brain metabolic state. 19 Moreover, targeted temperature management with normothermia lowered intracranial pressure and metabolic distress 36 and could, therefore, possibly mitigate GCE. Another option would be hypothermia, 37 which has so far not been tested in SAH patients with GCE in a prospective randomized controlled trial. Temperature levels were similar across our patients with early and delayed edema resolution, which may reflect aggressive fever management by targeting normothermia adopted in our institutional protocol.
Several limitations of the current study merit consideration. First, the timing of performed CT scans varied between patients because of the observational nature of the study which may have prompted a shift towards delayed resolution in good-grade patients. Patients who appeared clinically well without baseline edema, potentially could have developed asymptomatic edema at a later time point. Yet they would not have received repeated CT scans because there was no prospective protocol to get repeated imaging. Second, because of the retrospective analysis of prospectively collected data only associations but not causalities can be concluded. Third, this is a single-center study and may not be generalizable to other patients. Fourth, we did not reassess CT interrater reliability of SEBES grading since a high κ value of 0.89 has already been described in the original publication. 17 Finally, the aim of the study was not to find the most accurate multivariable model to predict edema resolution but to identify associations between routinely assessed parameters of disease severity and brain edema resolution.
Conclusions
This study demonstrates that the SEBES grade can quantify brain edema resolution and opens the opportunity to be used as a biomarker in clinical trials targeting treatment of GCE after SAH. Further prospective studies are needed to confirm the prognostic value of this biomarker and to test potential treatment interventions to modulate cerebral edema resolution.
